ES2171414T3 - Inmunoensayos para anticuerpos anti-hcv utilizando antigenos con epitopos conformacionales. - Google Patents

Inmunoensayos para anticuerpos anti-hcv utilizando antigenos con epitopos conformacionales.

Info

Publication number
ES2171414T3
ES2171414T3 ES93916942T ES93916942T ES2171414T3 ES 2171414 T3 ES2171414 T3 ES 2171414T3 ES 93916942 T ES93916942 T ES 93916942T ES 93916942 T ES93916942 T ES 93916942T ES 2171414 T3 ES2171414 T3 ES 2171414T3
Authority
ES
Spain
Prior art keywords
antigens
epithopes
hcv
conformational
hcv antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93916942T
Other languages
English (en)
Other versions
ES2171414T5 (es
Inventor
David Y Chien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25429280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2171414(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of ES2171414T3 publication Critical patent/ES2171414T3/es
Application granted granted Critical
Publication of ES2171414T5 publication Critical patent/ES2171414T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)

Abstract

METODOS DE INMUNOENSAYOS, UTILIZANDO ANTIGENOS DE ENVOLTURA HCV QUE CONTIENEN REACTIVOS DE EPITOPES CONFORMES CON ANTICUERPOS DE SUERO PROCEDENTE DE INDIVIDUOS INFECTADOS, SON UTILES PARA TAMIZAR Y DIAGNOSIS. ESTOS ANTIGENOS DETECTAN ANTICUERPOS QUE NO SE DETECTAN MEDIANTE ANTIGENOS DE ENVOLTURA HCV DESNATURALIZADA. ADEMAS, ESTOS ANTIGENOS DE ENVOLTURA HCV, COMPRENDIENDO EPITOPES CONFORMES, SON MAS REACTIVOS INMUNOLOGICAMENTE QUE UN NUMERO DE OTROS ANTIGENOS DE HCV. ESTA ES LA PRIMERA EVIDENCIA DE QUE EPITOPES CONFORMES PUEDEN ESTAR IMPLICADOS EN LA RESPUESTA INMUNOLOGICA A LOS ANTIGENOS DE HCV.
ES93916942T 1992-07-07 1993-07-02 Inmunoensayos para anticuerpos anti-hcv utilizando antigenos con epitopos conformacionales. Expired - Lifetime ES2171414T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91075992A 1992-07-07 1992-07-07
US910759 1992-07-07

Publications (2)

Publication Number Publication Date
ES2171414T3 true ES2171414T3 (es) 2002-09-16
ES2171414T5 ES2171414T5 (es) 2006-09-01

Family

ID=25429280

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93916942T Expired - Lifetime ES2171414T5 (es) 1992-07-07 1993-07-02 Inmunoensayos para anticuerpos anti-hcv utilizando antigenos con epitopos conformacionales.

Country Status (19)

Country Link
US (1) US20020150883A1 (es)
EP (1) EP0649537B2 (es)
JP (2) JP3490085B2 (es)
AT (1) ATE216779T1 (es)
AU (1) AU685059B2 (es)
CA (1) CA2139645C (es)
CZ (1) CZ291951B6 (es)
DE (1) DE69331845T3 (es)
DK (1) DK0649537T4 (es)
ES (1) ES2171414T5 (es)
FI (1) FI110546B (es)
HU (1) HUT70473A (es)
NO (1) NO321185B1 (es)
PL (1) PL174686B1 (es)
PT (1) PT649537E (es)
RU (1) RU2126158C1 (es)
SK (1) SK284556B6 (es)
UA (1) UA39944C2 (es)
WO (1) WO1994001778A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274148B1 (en) * 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
ES2174957T5 (es) * 1994-07-29 2006-12-16 Innogenetics N.V. Proteinas purificadas de envoltura de virus de la hepatitis c para uso diagnostico y terapeutico.
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
US5707385A (en) * 1994-11-16 1998-01-13 Advanced Cardiovascular Systems, Inc. Drug loaded elastic membrane and method for delivery
WO1996041196A1 (en) * 1995-06-07 1996-12-19 Abbott Laboratories Method for detection of antibody to hepatitis c virus second envelope glycoprotein
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
WO2000026673A1 (en) * 1998-11-03 2000-05-11 Abbott Laboratories Methods of detecting chronic infection caused by hcv
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
ES2279766T3 (es) * 1999-07-28 2007-09-01 Novartis Vaccines And Diagnostics, Inc. Sistemas de deteccion por inmunoensayos del antigeno viral de hepatitis c.
SI1354204T2 (sl) 2000-06-15 2010-09-30 Novartis Vaccines & Diagnostic Hcv antigen antitelo kombinacijska analiza
EP1829891B1 (en) 2000-06-15 2012-12-26 Novartis Vaccines and Diagnostics, Inc. Immunoassays for Anti-HCV Antibodies
RU2194993C2 (ru) * 2000-12-28 2002-12-20 Научно-исследовательский институт вирусологии им.Д.И.Ивановского РАМН Способы ускоренной диагностики гепатита с, основанные на обнаружении гемагглютининов вируса гепатита с и антител к ним в рга и ртга в крови людей
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
RU2192011C1 (ru) * 2001-11-26 2002-10-27 Иткес Александр Веньяминович Набор "микровирус" для обнаружения днк вич, интегрированной в хромосомы инфицированных клеток
ES2312806T3 (es) 2002-09-09 2009-03-01 Novartis Vaccines And Diagnostics, Inc. Ensayo de vhc.
WO2004064608A2 (en) * 2003-01-17 2004-08-05 Aethlon Medical, Inc. Method for removal of viruses from blood by lectin affinity hemodialysis
WO2004071414A2 (en) * 2003-02-05 2004-08-26 Genzyme Corporation Therapeutic anti-hcv (al9) compounds
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
EP1802778B1 (en) * 2004-08-27 2011-10-05 Novartis Vaccines and Diagnostics, Inc. Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof
US8216590B2 (en) 2006-08-25 2012-07-10 Novartis Ag HCV fusion polypeptides
EP3067048B1 (en) 2007-12-07 2018-02-14 GlaxoSmithKline Biologicals SA Compositions for inducing immune responses
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
JP2016512241A (ja) 2013-03-14 2016-04-25 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 改良された抗体検出のためのｈｃｖｎｓ３組換え抗原およびこの突然変異体
MX362075B (es) 2013-03-14 2019-01-07 Abbott Lab Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
WO2014143343A1 (en) 2013-03-14 2014-09-18 Abbott Laboratories Hcv core lipid binding domain monoclonal antibodies
CA2980718C (en) 2015-03-27 2021-06-01 Ortho-Clinical Diagnostics, Inc. Hcv ns4a/modified ns3 polypeptides and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
JPH02500880A (ja) 1987-11-18 1990-03-29 カイロン　コーポレイション Ｎａｎｂｖの診断用薬およびワクチン
KR0185373B1 (ko) 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
GR1001261B (el) * 1989-12-18 1993-06-30 Wellcome Found Ιϊκός παράγων.
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus
HU217025B (hu) * 1990-04-04 1999-11-29 Chiron Corp. Hepatitis C vírus-(HCV) antigénkészítmények az anti-HCV-antitestek kimutatására immunoassay-kben
DE69132332T2 (de) * 1990-04-06 2000-11-30 Genelabs Technologies, Inc. Hepatitis c-virus-epitope
AU652941B2 (en) * 1990-06-25 1994-09-15 Research Foundation For Microbial Diseases Of Osaka University, The Non-A, Non-B hepatitis virus particles
KR0181517B1 (ko) * 1990-07-09 1999-04-01 나까하라 노부유끼 비-에이 비-비형 간염-특이 항원 및 간염 진단에서 그의 용도
SK286106B6 (sk) * 1990-11-08 2008-03-05 Novartis Vaccines & Diagnostics, Inc. Spôsob vykonávania imunodiagnostickej skúšky na detekciu protilátky proti vírusu hepatitídy C
IT1249684B (it) * 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
JP3439209B2 (ja) * 1992-01-31 2003-08-25 アボツト・ラボラトリーズ Ｈｃｖ蛋白のための哺乳動物発現システム
US5587285A (en) * 1992-01-31 1996-12-24 University Of Texas System Generation serological assay for monitoring HIV exposure

Also Published As

Publication number Publication date
RU94046284A (ru) 1997-02-27
AU4662993A (en) 1994-01-31
FI110546B (fi) 2003-02-14
EP0649537B2 (en) 2006-02-22
DK0649537T3 (da) 2002-06-17
DK0649537T4 (da) 2006-04-10
PL174686B1 (pl) 1998-08-31
AU685059B2 (en) 1998-01-15
EP0649537B1 (en) 2002-04-24
DE69331845D1 (de) 2002-06-06
EP0649537A1 (en) 1995-04-26
SK495A3 (en) 1995-07-11
JP2003329687A (ja) 2003-11-19
JP3490085B2 (ja) 2004-01-26
FI950002L (fi) 1995-02-27
CZ695A3 (en) 1996-03-13
DE69331845T3 (de) 2006-10-05
CA2139645A1 (en) 1994-01-20
HUT70473A (en) 1995-10-30
WO1994001778A1 (en) 1994-01-20
RU2126158C1 (ru) 1999-02-10
NO321185B1 (no) 2006-04-03
CA2139645C (en) 2003-02-11
PL307178A1 (en) 1995-05-02
JPH07509060A (ja) 1995-10-05
PT649537E (pt) 2002-09-30
FI950002A0 (fi) 1995-01-02
NO950006D0 (no) 1995-01-02
US20020150883A1 (en) 2002-10-17
CZ291951B6 (cs) 2003-06-18
ES2171414T5 (es) 2006-09-01
DE69331845T2 (de) 2002-08-14
SK284556B6 (sk) 2005-06-02
ATE216779T1 (de) 2002-05-15
NO950006L (no) 1995-02-24
HU9500008D0 (en) 1995-03-28
UA39944C2 (uk) 2001-07-16

Similar Documents

Publication Publication Date Title
ES2171414T3 (es) Inmunoensayos para anticuerpos anti-hcv utilizando antigenos con epitopos conformacionales.
MX168290B (es) Equipo para utilizar en la realizacion de un inmunoensayo para la deteccion de antigenos virales y metodo de uso del inmunoensayo
NO870412L (no) Peptider.
NO923839D0 (no) Kombinasjoner av hepatitt c-virus(hcv)-antigener for anvendelse i immunoanalyser for anti-hcv-antistoffer
ATE1614T1 (de) Immunologisches bestimmungsverfahren.
ES2065935T3 (es) Anticuerpos monoclonales de raton para hiv-i p24 y su uso en ensayos de diagnostico.
ES2180754T3 (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
KR920001200A (ko) 고체상 면역분석방법
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
SE9000595D0 (sv) New peptides, diagnostic antigens and an immunoassay method
ES520012A0 (es) Procedimiento de aglutinacion con latex para la deteccion o la determinacion de un participante en una reaccion inmunologica.
ES2094124T3 (es) Ensayo-inmunologico de anticuerpos contra hiv.
SE8601695D0 (sv) Fast-fasanalysmetod
MY100476A (en) Supported viral antigen and preparation and use thereof
SE9101863D0 (sv) Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
MX170503B (es) , "procedimiento para obtener un reactivo antigenico util para determinar indirectamente salmonella typhi.
Bocchieri An ELISA for anti-thymocyte autoantibody in NZB mice Comparison with the cytotoxic assay
Saluzzo et al. Specific ELISA-IgM antibodies for diagnosis and epidemiological surveillance of flaviviruses in Africa.
Huebschle et al. ELISA for the detection of Teschen virus antibodies in pig sera.
KR900018368A (ko) 하나 또는 그 이상의 관련 비루스의 항원에 대해 지시된 항체 검출용 진단 시험물

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 649537

Country of ref document: ES